slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 17,791-17,820
Pages 3,950
Rows per page 30
Component
17,791-17,820 of 118,471
07
The slide uses a highly critical, investigative tone, framing the company as fraudulent and the drug as dangerous.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes3 hits
08
The slide uses a narrative structure to frame the drug's history as a series of red flags and industry failures.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes3 hits
11
The slide uses a narrative-based evidence approach to build a case against the drug's safety profile.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster3 hits
13
The slide uses a 'villain critique' style to undermine the company's marketing claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster3 hits
19
The slide uses a narrative structure to expose potential accounting opacity and price-driven revenue growth.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster3 hits
25
The slide uses highly critical, adversarial language ('toxic drug', 'face-planted', 'questionable French lab') to frame the company negatively.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment3 hits
56
The slide uses a direct quote from scientific literature to establish a causal link between the drug's mechanism and its side effects.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal3 hits
57
The slide uses a specific research paper abstract to validate the claim of inherent cardiotoxicity.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal3 hits
74
The slide uses a combination of narrative summary and a direct excerpt from a scientific review paper to validate the difficulty of the target.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
75
The slide uses a 'before-after' narrative structure to show that shifting chemical scaffolds did not solve the underlying safety issues in H3 receptor drug development.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
76
The slide uses excerpts from scientific literature to frame the technical hurdles in CNS drug development.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
77
The slide uses a 'villain critique' approach by leveraging a peer's own research to undermine the target's (Bioprojet/pitolisant) technology.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
87
The slide uses a Q&A transcript format to validate the thesis that the drug class is fundamentally flawed.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
97
The slide uses highlighted text to emphasize key claims about compound quality and pharmacokinetic challenges.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
102
Uses Q&A format to frame expert opinion as a critique of Bioprojet's claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
110
The slide uses a 'before-after' or 'comparison' structure to highlight the exclusion criteria in two different trial papers.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
115
The slide uses a red underline to emphasize the specific clinical findings in the excerpt.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
142
The slide uses direct excerpts from regulatory documents to challenge the company's claims regarding drug safety and pharmacokinetics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
151
Uses anecdotal evidence from Facebook patient support groups to highlight a safety gap.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
152
The slide uses red underlining to highlight specific dangerous medical advice given to patients.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
154
The slide uses a 'villain critique' style to frame the FDA's approval as flawed and the drug's safety as compromised.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
166
The slide uses a scientific table to challenge the 'no appreciable binding' claim found in a drug's package insert, citing reproducibility concerns regarding the source of that claim.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
137
The slide uses direct quotes to frame IonQ's technology as inferior to its competitor, Honeywell.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
139
The slide uses a Q&A transcript format to expose the lack of revenue generation from IonQ's partners.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
146
Uses SEC filing excerpts to highlight related-party dependency.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated3 hits
147
The slide uses a 'round-tripping' argument, contrasting revenue received from related parties against expenses paid to them.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated3 hits
162
The slide uses a Q&A format to present whistleblower testimony.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
167
The slide uses highlighted text to emphasize key claims about manufacturing bottlenecks, design similarity, and the lack of technical moat.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
173
The slide uses highlighted text to emphasize key claims about the co-founders' behavior and lack of presence.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
174
The slide uses Q&A transcripts to build a narrative of leadership negligence and physical absence.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits